Literature DB >> 2826608

Ganciclovir for treatment of renal transplant-associated primary cytomegalovirus pneumonia.

D W Hecht1, D R Snydman, C S Crumpacker, B G Werner, B Heinze-Lacey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2826608     DOI： 10.1093/infdis/157.1.187

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  12 in total

Review 1.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

2.  Population pharmacokinetics of ganciclovir following administration of valganciclovir in paediatric renal transplant patients.

Authors:  Wei Zhao; Véronique Baudouin; Daolun Zhang; Georges Deschênes; Chantal Le Guellec; Evelyne Jacqz-Aigrain
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

3.  DRUG THERAPY OF CYTOMEGALOVIRUS INFECTIONS.

Authors:  S Shankar; P C Sanchetee
Journal:  Med J Armed Forces India       Date:  2017-06-26

4.  Use of ganciclovir in the treatment of acquired cytomegalovirus disease in a preterm infant.

Authors:  H Amin; T Jadavji; R Sauve; J Gill
Journal:  Can J Infect Dis       Date:  1990

Review 5.  Acquisition of cytomegalovirus infection: an update.

Authors:  B A Forbes
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

Review 6.  Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections.

Authors:  D Faulds; R C Heel
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

Review 7.  Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

Authors:  Daniel S Owers; Angela C Webster; Giovanni F M Strippoli; Kathy Kable; Elisabeth M Hodson
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

8.  Prospective cytomegalovirus surveillance in paediatric renal transplant patients.

Authors:  S Iragorri; D Pillay; M Scrine; R S Trompeter; L Rees; P D Griffiths
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

Review 9.  New antiherpesvirus agents. Their targets and therapeutic potential.

Authors:  F A Alrabiah; S L Sacks
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

10.  Cytomegalovirus infections in renal transplant patients.

Authors:  X G Zhang; M K Chan
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.